logo
Twitter
Discord
Email
logo
Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc.

NYSE•MD
CEO: Mr. Mark S. Ordan
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 1995-09-20
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Contact Information
1301 Concord Terrace, Sunrise, FL, 33323, United States
954-384-0175
www.pediatrix.com
Market Cap
$1.51B
P/E (TTM)
13.7
vs Industry 17.9
Dividend Yield (TTM)
--
52W High
$18.22
52W Low
$11.84
52W Range
87%
2.7
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 2.7 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024

Financial Dashboard

Q2 2025 Data

Revenue

$468.84M-7.03%
4-Quarter Trend

EPS

$0.45-124.46%
4-Quarter Trend

FCF

$132.65M+32.67%
4-Quarter Trend

Earnings Highlights

Key Highlights

No Data Available

Risk Factors

No Data Available

Outlook

No Data Available

Peer Comparison

Revenue (TTM)

Select Medical Holdings CorporationSEM
$5.77B
-16.1%
AdaptHealth Corp.AHCO
$3.04B
-6.7%
Astrana Health, Inc.ASTH
$2.42B
+52.0%

Gross Margin (Latest Quarter)

Novavax, Inc.NVAX
94.1%
+2.7 pp
GoodRx Holdings, Inc.GDRX
83.7%
-1.9 pp
CONMED CorporationCNMD
55.0%
+2.7 pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
SEM$1.76B12.87.8%50.1%
ASTH$1.59B61.93.6%3.3%
MD$1.51B13.714.1%30.9%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4-Quarter Revenue CAGR
-2.8%
Flat Growth
4-Quarter Net Income CAGR
+26.4%
Significant Improvement in Profitability
Cash Flow Stability
75%
Volatile Cash Flow

Research & Insights

Reports
All Years
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 5, 2025|
    Revenue: $468.84M-7.0%
    |
    EPS: $0.45-124.5%
    Beat
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 6, 2025|
    Revenue: $458.36M-7.4%
    |
    EPS: $0.24+400.0%
    Meet
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 20, 2025|
    Revenue: $2.01B+0.9%
    |
    EPS: $-1.19-65.3%
    Miss
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 1, 2024|
    Revenue: $511.16M+0.9%
    |
    EPS: $0.23-53.1%
    Miss
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 6, 2024|
    Revenue: $504.30M+0.7%
    |
    EPS: $-1.84-641.2%
    Miss
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 7, 2024|
    Revenue: $495.10M+0.8%
    |
    EPS: $0.05-71.8%
    Miss
  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 20, 2024|
    Revenue: $1.99B+1.1%
    |
    EPS: $-0.72-191.1%
    Miss
  • Form 10-Q - Q3 2023

    Period End: Sep 30, 2023|Filed: Nov 2, 2023|
    Revenue: $506.61M+3.4%
    |
    EPS: $0.49+32.4%
    Beat